Proliferative potential in pituitary adenomas: Measurement by monoclonal antibody MIB-1

Acta Neurochirurgica

Volumn 139, Issue 7, 1997, Pages 613-618

  Abe, T ^a   Sanno, N ^b   Osamura, Y R ^b   Matsumoto, K ^a  

^a SHOWA UNIVERSITY   (Japan)

^b TOKAI UNIVERSITY   (Japan)

Author keywords

Magnetic resonance imaging; Monoclonal antibody; Pituitary adenoma; Proliferative potential; Regrowth

Indexed keywords

HYPOPHYSIS HORMONE; MONOCLONAL ANTIBODY KI 67;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOLOGY; BLEEDING; CANCER RECURRENCE; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMPARATIVE STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; MALE; MEASUREMENT; PRIORITY JOURNAL; RADIOLOGY; TREATMENT PLANNING;

ADENOMA; ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, NUCLEAR; CELL DIVISION; FEMALE; HUMANS; KI-67 ANTIGEN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PITUITARY NEOPLASMS;

EID: 0030762380     PISSN: 00016268     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01411995     Document Type: Article

References (28)

1. Anniko M, Holm L-E, Wersäll J (1983) Aggressive pituitary tumor growth. Arch Otorhinolaryngol 238: 53-62
2. Ekramullah SM, Saitoh Y, Ohnishi T, Arita N, Taki T, Hayakawa T (1995) Effects of bromocriptine on staining indices of Ki-67 and proliferating cell nuclear antigen, and nucleolar organizer region number in pituitary adenomas. Neurol Med Chir (Tokyo) 35: 221-226
3. Gerdes J, Lemke H, Baisch H, Wacker H-H, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710-1715
4. Key G, Becker MHG, Baron B, Duchrow M, Schlüter C, Flad H-D, Gerdes J (1993) New Ki-67-equivalent murine monoclonal antibodies (MIB1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest 68: 629-639
5. Knosp E, Kitz K, Perneczky A (1989) Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67. Neurosurgery 25: 927-930
6. Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33: 610-618
7. Landolt AM (1990) Transsphenoidal surgery of pituitary tumors: its pitfalls and complications. In: Landolt AM (eds) Progress in neurological surgery, Vol 13. Karger, Basel, pp 1-30
8. Landolt AM, Shibata T, Kleihues P (1987) Growth rate of human pituitary adenomas. J Neurosurg 67: 803-806
9. Mountcastle RB, Roof BS, Mayfield RK, Mordes DB, Sagel J, Biggs PJ, Rawe SE (1989) Pituitary adenocarcinoma in an acromegalic patient. Response to bromocriptine and pituitary testing: a review of the literature on 36 cases of pituitary carcinoma. Am J Med Sci 298: 109-118
10. Nagashima T, Murovic JA, Hoshino T, Wilson CB, De Armond SJ (1986) The proliferative potential of human pituitary tumors in situ. J Neurosurg 64: 588-593
11. Nakamura H, Morita T, Masaki S, Yoshida S (1984) Intracellular localization and metabolism of DNA polymerase α in human cells visualized with monoclonal antibody. Exp Cell Res 151: 123-133
12. Nishioka H, Akada K, Akimoto J, Ito H (1993) GH-secreting pituitary adenomas - correlation between clinical features, growth potential and histopathological studies. No To Shinkei 45: 1019-1025
13. Numoto RT (1994) Pineal parenchymal tumors. Cell differentiation and prognosis. J Cancer Res Clin Oncol 120: 683-690
14. Onda K, Davis RL, Shibuya M, Wilson CB, Hoshino T (1994) Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas. Cancer 74: 1921-1926
15. Pollock BE, Kondziolka D, Lunsford LD, Flickinger JC (1994) Stereotactic 'radiosurgery' for pituitary 'adenomas': imaging, visual and endocrine results. Acta Neurochir (Wien) [Suppl]: 33-38
16. Saito K, Kuwayama A, Yamamoto N, Sugita K (1995) The transsphenoidal removal of nonfunctioning pituitary adenomas with suprasellar extensions: the open sella method and intentionally staged operation. Neurosurgery 36: 668-676
17. Sallinen PK, Haapasalo HK, Visakorpi T, Helen PT, Rantala IS, Isola JJ, Helin HJ (1994) Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples. J Pathol 174: 275-282
18. Scheithauer BW, Kovacs KT, Laws ER Jr, Randall RV (1986) Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg 65: 733-744
19. Selman WR, Laws ER Jr, Scheithauer BW, Carpenter SM (1986) The occurrence of dural invasion in pituitary adenomas. J Neurosurg 64: 402-407
20. Shi S-R, Key ME, Kalra KL (1991) Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39: 741-748
21. Shibuya M, Osamura RY (1993) Comparison of proliferate potential in pituitary adenoma. Monoclonal antibody MIB-1 and nucleolar organizer regions. Clin Endocrinol 41: 59-63
22. Shibuya M, Saito F, Miwa T, Davis RL, Wilson CB, Hoshino T (1992) Histochemical study of pituitary adenomas with Ki-67 and anti-DNA polymerase α monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts. Acta Neuropathol 84: 178-183
23. Shibuya M, Utsunomiya H, Osamura RY (1993) Immunohistochemical staining of proliferative cells with MIB-1 monoclonal antibody. Pathol Clin Med 11: 373-377
24. Taylor WAS, Uttley D, Wilkins PR (1994) Multiple dural metastases from a pituitary adenoma: case report. J Neurosurg 81: 624-626
25. Terada T, Kovacs K, Stefaneanu L, Horvath E (1995) Incidence, pathology, and recurrence of pituitary adenomas: study of 647 unselected surgical cases. Endocrine Pathol 6: 301-310
26. Thapar K, Kovacs K, Scheithauer BW, Stefaneanu L, Horvath E, Pernicone PJ, Murray D, Laws ER Jr (1996) Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery 38: 99-107
27. Zagzag D, Friedlander DR, Miller DC, Dosik J, Cangiarella J, Kostianovsky M, Cohen H, Grumet M (1995) Tenascin expression in astrocytomas correlates with angiogenesis. Cancer Res 55: 907-914
28. Zorludemir S, Scheithauer BW, Hirose T, Van Houten C, Miller G, Meyer FB (1995) Clear cell meningioma. A clinicopathologic study of a potentially aggressive variant of meningioma. Am J Surg Pathol 19: 493-505